Page 15 - Morphosys Customs Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys customs inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Customs Inc Today - Breaking & Trending Today

MorphoSys AG Reports First Quarter 2023 Financial Results

Monjuvi U.S. net product sales of US$ 20.8 million (€ 19.4 million) for the first quarter of 2023 Enrollment of Phase 3 MANIFEST-2 study of pelabresib in first-line myelofibrosis is complete, with topline ....

United States , United Kingdom , Charlotte Lohmann , Jean Paul Kress , Thomas Biegi , Lucinda Crabtree , Monjuvi Minjuvi , Julia Neugebauer , Eamonn Nolan , American Association For Cancer Research , Janssen Biotech Inc , Morphosys Group Key Figures , Exchange Commission , Drug Administration , American Society Of Clinical Oncology , Share Of Loss Associates , Xencor Inc , Development Rd Expenses , Chief Executive Officer , Chief Financial Officer , Management Board , Chief Legal Officer , Morphosy Management Board , Events After , First Quarter , Data Highlight ,

MorphoSys (MOR) Scheduled to Post Quarterly Earnings on Wednesday

MorphoSys (NASDAQ:MOR – Get Rating) is set to release its earnings data after the market closes on Wednesday, May 3rd. Investors that are interested in registering for the company’s conference call can do so using this link. MorphoSys Trading Down 2.1 % Shares of MOR traded down $0.11 during trading hours on Tuesday, reaching $5.24. […] ....

Jpmorgan Chase Co , Virtu Financial , Morphosys Company Profile , Morgan Stanley , T Rowe Price Investment Management Inc , Citadel Advisors , Get Rating , Sys Trading Down , Price Investment Management , Morphosys Daily , Nasdaq Mor ,

MorphoSys AG (NASDAQ:MOR) Sees Large Drop in Short Interest

MorphoSys AG (NASDAQ:MOR – Get Rating) was the target of a large decline in short interest during the month of April. As of April 15th, there was short interest totalling 28,700 shares, a decline of 13.3% from the March 31st total of 33,100 shares. Based on an average daily volume of 111,400 shares, the short-interest […] ....

Citadel Advisors , Virtu Financial , Alphacentric Advisors , Morgan Stanley , T Rowe Price Investment Management Inc , Jpmorgan Chase Co , Get Rating , Capital Management , Centric Advisors , Price Investment Management , Morphosys Daily , Nasdaq Mor ,

MorphoSys (ETR:MOR) Stock Price Down 0.7%

MorphoSys AG (ETR:MOR – Get Rating) shares were down 0.7% during trading on Thursday . The stock traded as low as €18.47 ($20.52) and last traded at €18.94 ($21.04). Approximately 88,739 shares were traded during trading, a decline of 42% from the average daily volume of 153,687 shares. The stock had previously closed at €19.08 […] ....

United States , Goldman Sachs Group , Morgan Stanley , Jpmorgan Chase Co , Get Rating , Morphosys Daily , Petr Mor ,

MorphoSys (MOR) Scheduled to Post Quarterly Earnings on Wednesday

MorphoSys (NASDAQ:MOR – Get Rating) will be announcing its earnings results after the market closes on Wednesday, May 3rd. MorphoSys Trading Up 2.5 % Shares of MorphoSys stock opened at $5.29 on Friday. The company has a debt-to-equity ratio of 1.85, a current ratio of 3.91 and a quick ratio of 3.83. MorphoSys has a […] ....

T Rowe Price Investment Management Inc , Citadel Advisors , Virtu Financial , Jpmorgan Chase Co , Morgan Stanley , Get Rating , Price Investment Management , Morphosys Daily , Nasdaq Mor ,